C/EBP homologous protein is necessary for normal osteoblastic function

Journal of Cellular Biochemistry

Volumn 97, Issue 3, 2006, Pages 633-640

  Pereira, Renata C ^a,b   Stadmeyer, Lisa ^a   Marciniak, Stefan J ^c   Ron, David ^c   Canalis, Ernesto ^a,b  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone formation; CCAAT enhancer binding proteins; Osteoblasts; Transcriptional factors

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN HOMOLOGOUS PROTEIN; COLLAGEN TYPE 1; MESSENGER RNA; OSTEOCALCIN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE REMODELING; CALVARIA; CELL COUNT; CELL FUNCTION; CELL SURFACE; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; MALE; MORPHOMETRICS; MOUSE; MOUSE STRAIN; NONHUMAN; NORTHERN BLOTTING; OSSIFICATION; OSTEOBLAST; OSTEOBLASTOGENESIS; OSTEOCLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; X RAY ANALYSIS;

ANIMALS; BLOTTING, NORTHERN; BONE DENSITY; COLLAGEN TYPE I; FEMALE; HOMOZYGOTE; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOMOGRAPHY, X-RAY COMPUTED; TRANSCRIPTION FACTOR CHOP;

ANIMALIA;

EID: 33144455022     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20660     Document Type: Article

References (36)

1. 1/S arrest. Genes Dev 8:453-464.
2. Batchvarova N, Wang XZ, Ron D. 1995. Inhibition of adipogenesis by the stress-induced protein CHOP (GADD153). EMBO J 14:4654-4661.
3. Bianco P, Robey PG. 2000. Marrow stromal stem cells. J Clin Invest 105:1663-1668.
4. Canalis E, Centrella M, Burch W, McCarthy T. 1989. Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 83:60-65.
5. Canalis E, Economides AE, Gazzerro E. 2003. Bone morphogenetic proteins, their antagonists and the skeleton. Endocr Rev 24:218-235.
6. Chen AE, Ginty DD, Fan CM. 2005. Protein kinase A signaling via CREB controls myogenesis induced by Wnt proteins. Nature 433:317-322.
7. Darlington GJ, Ross SE, MacDougald OA. 1998. The role of C/EBP genes in adipocyte differentiation. J Biol Chem 273:30057-30060.
8. Delany AM, Durant D, Canalis E. 2001. Glucocorticoid suppression of IGF I transcription in osteoblasts. Mol Endocrinol 15:1781-1789.
9. Devlin RD, Du Z, Buccilli V, Jorgetti V, Canalis E. 2002. Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia. Endocrinology 143: 3955-3962.
10. Gazzerro E, Deregowski V, Vaira S, Canalis E. 2005. Overexpression of twisted gastrulation inhibits bone morphogenetic protein action and prevents osteoblast cell differentiation in vitro. Endocrinology 146:3875-3882.
11. Genovese C, Rowe D, Kream B. 1984. Construction of DNA sequences complementary to rat alpha I and alpha 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. Biochemistry 23:6210-6216.
12. Gutierrez S, Javed A, Tennant DK, van Rees M, Montecino M, Stein GS, Stein JL, Lian JB. 2002. CCAAT/enhancer-binding proteins (C/EBP) β and δ activate osteocalcin gene transcription and synergize with runx2 at the C/EBP element to regulate bone-specific expression. J Biol Chem 277:1316-1323.
13. Hanson RW. 1998. Biological role of the isoforms of C/EBP minireview series. J Biol Chem 273:28543.
14. -/- mice reveals a role for translational control in secretory cell survival. Mol Cell 7:1153-1163.
15. Lee YH, Sauer B, Johnson PF, Gonzalez FJ. 1997. Disruption of the c/ebpα gene in adult mouse liver. Mol Cell Biol 17:6014-6022.
16. Lian J, Stewart C, Puchacz E, Mackowiak S, Shalhoub V, Collart D, Zambetti G, Stein G. 1989. Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci USA 86:1143-1147.
17. Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R, Nagata K, Harding HP, Ron D. 2004. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 18:3066-3077.
18. Margolis RN, Canalis E, Partridge NC. 1996. Anabolic hormones in bone: Basic research and therapeutic potential. J Clin Endocrinol Metab 81:872-877.
19. Nagy TR, Prince CW, Li J. 2001. Validation of peripheral dual-energy X-ray absorptiometry for the measurement of bone mineral in intact and excised long bones of rats. J Bone Miner Res 16:1682-1687.
20. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. 1987. Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595-610.
21. Park JS, Luethy JD, Wang MG, Fargnoli J, Fornace AJ Jr., McBride OW, Holbrook NJ. 1992. Isolation, characterization, and chromosomal localization of the human GADD153 gene. Gene 116:259-267.
22. Pereira RC, Delany AM, Canalis E. 2002. Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: Correlation with CCAAT-enhancer binding protein expression. Bone 30:685-691.
23. Pereira RC, Delany AM, Canalis E. 2004. CCAAT/enhancer binding protein homologous protein (CHOP) induces osteoblastic differentiation. Endocrinology 145:1952-1960.
24. Perez-Losada J, Pintado B, Gutierrez-Adan A, Flores T, Banares-Gonzalez B, Calabia del Campo J, Martin-Martin JF, Battaner E, Sanchez-Garcia I. 2000. The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. Oncogene 19: 2413-2422.
25. Ramji DP, Foka P. 2002. CCAAT/enhancer-binding proteins: Structure, function, and regulation. Biochem J 365:561-575.
26. Ron D, Habener JF. 1992. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev 6: 439-453.
27. Tanaka T, Yoshida N, Kishimoto T, Akira S. 1997. Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene. Eur Med Biol Org J 16: 7432-7443.
28. Thiel G, Al Sarragj J, Vinson C, Stefano L, Bach K. 2005. Role of basic region leucine zipper transcription factors cyclic AMP response element binding protein (CREB), CREB2, activating transcription factor 2 and CAAT/ enhancer binding protein α in cyclic AMP response element-mediated transcription. J Neurochem 92:321-336.
29. Ubeda M, Wang XZ, Zinszner H, Wu I, Habener J, Ron D. 1996. Stress-induced binding of transcription factor CHOP to a novel DNA-control element. Mol Cell Biol 16:1479-1489.
30. Ubeda M, Vallejo M, Habener JF. 1999. CHOP enhancement of gene transcription by interactions with Jun/Fos AP-1 complex proteins. Mol Cell Biol 19:7589-7599.
31. Wang XZ, Kuroda M, Sok J, Batchvarova N, Kimmel R, Chung P, Zinszner H, Ron D. 1998. Identification of novel stress-induced genes downstream of chop. EMBO J 17: 3619-3620.
32. Westendorf JJ, Kahler RA, Schroeder TM. 2004. Wnt signaling in osteoblasts and bone diseases. Gene 341: 19-39.
33. Yamanaka R, Lekstrom-Himes J, Barlow C, Wynshaw-Boris A, Xanthopoulos KG. 1998. CCAAT/enhancer binding proteins are critical components of the transcriptional regulation of hematopoiesis. Int J Mol Med 1:213-221.
34. Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka HC, Schinke T, Li L, Brancorsini S, Sassone-Corsi P, Townes TM, Hanauer A, Karsenty G. 2004. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology: Implication for Coffin-Lowry Syndrome. Cell 117:387-398.
35. Yu VWC, Ambartsoumain G, Verlinden L, Moir JM, Prud'homme J, Gauthier C, Roughley PJ, St-Arnaud R. 2005. FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice. J Cell Biol 169: 591-601.
36. Zhang P, McGrath B, Li S, Frank A, Zambito F, Reinert J, Gannon M, Ma K, McNaughton K, Cavener DR. 2002. The PERK eukaryotic initiation factor 2α kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas. Mol Cell Biol 22:3864-3874.